Sperling Prostate Center

10/14/2026

🍅 Can what you eat help protect your prostate? This medically reviewed guide from Health highlights eight foods, from tomatoes and fatty fish to broccoli and soy, that research suggests may help lower the risk of prostate cancer.

Tomatoes, fatty fish, and soybeans are among the foods that support prostate health.

10/09/2026

For nearly 40 years, prostate cancer screening has started with a single question: What is his PSA?

A urologist at Fox Chase Cancer Center makes the case that the better question is whether a man has a prostate cancer worth finding.

In one randomized trial of more than 13,000 men, an MRI-targeted biopsy strategy reduced detection of clinically insignificant cancers by 54%, while detection of significant cancers was not meaningfully different.

Robert Uzzo, MD, MBA, of Fox Chase Cancer Center discusses an evolution in prostate cancer screening modalities.

10/08/2026

💬 "You're going to beat this." "Stay positive." "It's a good type of cancer to have."

These phrases are well-meant, but experts say they can minimize what a person with prostate cancer is going through.

Here's what to say instead, and why listening often matters more than finding the perfect words.

Learn what not to say to someone with prostate cancer and discover supportive alternatives to help loved ones feel heard, validated, and understood.

09/30/2026

A low PSA result is reassuring, and most of the time it is also correct. But a large Swedish screening study found clinically significant prostate cancer in a meaningful number of men whose PSA sat between 1.8 and 3.0, well inside the range most would consider safe.

Some aggressive cancer cell lines simply do not express much PSA, which is why imaging can still matter when the bloodwork looks fine.

Some uncommon high-grade prostate cancers are clinically significant but do not express PSA as a signal of their presence.

09/29/2026

Men in the US live shorter lives, develop chronic disease at higher rates, and use preventive care less often than women do.

The State of Men's Health Act, now introduced in both the House and the Senate, would establish a federal Office of Men's Health to coordinate a national response to those gaps.

The American Urological Association has backed the legislation and, with partner organizations, launched the Men's Health Policy Alliance to support it.

This FAQ outlines what the State of Men's Health Act would do, how a federal Office of Men’s Health could affect research and clinical care, and what urologists can do to support the effort.

09/28/2026

Erectile dysfunction is easy to write off as an inevitable part of getting older, or as a problem that stands on its own. But doctors warn it may be a sign of more serious health problems.

Persistent ED is often tied to cardiovascular disease, and the two conditions share many of the same risk factors, which makes it a signal worth raising with your physician rather than quietly managing.

Erectile dysfunction can be an early warning sign of heart disease, diabetes, or other health conditions. Learn what persistent ED may reveal about your overall health....

09/25/2026

An analysis of nearly 2,000 patient reviews of interventional radiologists found satisfaction came down to three things:

✅ Clear doctor-patient communication
✅ Achieving the outcome the patient was hoping for, and
✅ A physician who understood and respected their background and culture.

The single most common complaint had nothing to do with clinical skill. It was wait time.

What truly makes patients feel satisfied with their care? A study highlights three essential ingredients beyond clinical treatment.

09/24/2026

If you are on active surveillance, the repeat biopsy is often the hardest part of it.

In a study of 330 men with Grade Group 1 prostate cancer, a urine test called MyProstateScore 2.0-Active Surveillance identified roughly 97% of the cancers that had progressed to Grade Group 3 or higher, while potentially avoiding 64% of the biopsies that turned out to be unnecessary.

It outperformed MRI in a direct comparison, which points toward surveillance that requires fewer procedures.

Learn more about the study here 👉 https://pubmed.ncbi.nlm.nih.gov/42048777/

09/24/2026

📈 Prostate cancer diagnoses in the U.S. rose about 3% a year between 2014 and 2022, and the steepest increase was in advanced-stage disease, according to the American Cancer Society.

ACS experts say that means screening is happening too late for many men.

When prostate cancer is found before it spreads, the 5-year relative survival rate is more than 99%.

If you haven’t talked with your doctor about your personal risk and when to start screening, now is a good time to start.

Prostate cancer cases are rising in the United States, including advanced-stage diagnoses. Experts say screening may help detect the disease earlier, when it is easier to treat.

09/16/2026

One doctor says men don’t put enough effort into preventive care. Ignoring screenings for prostate, colon, skin and lung cancer when indicated may make the difference between success or failure of treatment.

Dr. David Shusterman, a board-certified urologist, told The Post which problems men dismiss — but should see their doctor about ASAP.